M-TERIFLUNOMIDE 14 MG
TERIFLUNOMIDE : 14 MG · DIN 02523833 · MANTRA PHARMA INC
Health Canada status: MARKETED
What is M-TERIFLUNOMIDE?
M-TERIFLUNOMIDE 14 MG contains TERIFLUNOMIDE : 14 MG. It is listed in the Health Canada Drug Product Database under DIN 02523833, held by MANTRA PHARMA INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 16-May-2022. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is M-TERIFLUNOMIDE used for?
M-TERIFLUNOMIDE (teriflunomide) is indicated for: monotherapy for the treatment of patients with relapsing remitting multiple sclerosis (RRMS) to reduce the frequency of clinical exacerbations and to delay the accumulation of physical disability. M-TERIFLUNOMIDE should only be prescribed by clinicians who are experienced in the diagnosis and management of multiple sclerosis.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02523833 |
|---|---|
| Brand name | M-TERIFLUNOMIDE |
| Generic / active ingredient | TERIFLUNOMIDE : 14 MG |
| Manufacturer | MANTRA PHARMA INC |
| Strength | 14 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | L04AK02 TERIFLUNOMIDE |
| AHFS class | 90:04.20 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 16-May-2022 |
| Original market date | 2022-05-16 00:00:00 |
How is it stored and handled?
null
How is it supplied?
Carton of 30 tablets of 14 mg containing three blisters composed of 10 tablets per blister.
What can be used instead?
Other Canadian products sharing ATC code L04AK02 TERIFLUNOMIDE. 7 of 11 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| APO-TERIFLUNOMIDE | 14 MG | TABLET | APOTEX INC | MARKETED | DIN 02500639 |
| JAMP TERIFLUNOMIDE | 14 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED | DIN 02504170 |
| NAT-TERIFLUNOMIDE | 14 MG | TABLET | NATCO PHARMA (CANADA) INC | MARKETED | DIN 02500310 |
| PMS-TERIFLUNOMIDE | 14 MG | TABLET | PHARMASCIENCE INC | MARKETED | DIN 02500434 |
| SANDOZ TERIFLUNOMIDE | 14 MG | TABLET | SANDOZ CANADA INCORPORATED | MARKETED | DIN 02505843 |
| TEVA-TERIFLUNOMIDE | 14 MG | TABLET | TEVA CANADA LIMITED | MARKETED | DIN 02501090 |
| ACH-TERIFLUNOMIDE | 14 MG | TABLET | ACCORD HEALTHCARE INC | CANCELLED POST MARKET | DIN 02502933 |
| AUBAGIO | 14 MG | TABLET | SANOFI-AVENTIS CANADA INC | CANCELLED POST MARKET | DIN 02416328 |
| AURO-TERIFLUNOMIDE | 14 MG | TABLET | AURO PHARMA INC | APPROVED | DIN 02500515 |
| MAR-TERIFLUNOMIDE | 14 MG | TABLET | MARCAN PHARMACEUTICALS INC | CANCELLED POST MARKET | DIN 02500469 |
Who else supplies TERIFLUNOMIDE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. TERIFLUNOMIDE appears in 175 registered pack listings across 14 markets, published on 11 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.